Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.World journal of gastroenterology · 2005
   Trial
2. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.Wiener klinische Wochenschrift · 2004
   Trial
3. Tegoprazan-Amoxicillin Dual Therapy for Clarithromycin-ResistantMicroorganisms · 2025
   Article
4. Overcoming the effects of increasing antimicrobial resistance onExpert review of gastroenterology & hepatology · 2024
   Review
5. Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial.Trials · 2024
   Article
6. Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment ofTropical medicine and infectious disease · 2023
   Review
7. Rapid identification ofThe journal of pathology. Clinical research · 2017
   Article
8. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
   Article
9. Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2011
   Article
10. Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy.World journal of gastroenterology · 2007
    Review
11. Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.World journal of gastroenterology · 2003
    Article
12. Recombinant Helicobacter pylori catalase.World journal of gastroenterology · 2003
    Article
13. Prospective cohort study of comprehensive prevention to gastric cancer.World journal of gastroenterology · 2003
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.